UC Professors Named American Association for the Advancement of Science Fellows
Peter Stambrook, PhD, professor and chairman of the UC College of Medicines cell and cancer biology department, and Robert Richardson, PhD, professor of philosophy in the McMicken College of Arts and Sciences, received the national honor.
Stambrook and Richardson are among 471 AAAS members recognized in 2007 for their scientifically or socially distinguished efforts to advance science or its applications.
AAAS fellowship status is given annually to distinguished individuals by society members and their peers. UC has 14 faculty members who are AAAS fellowsnine from the
This years Fellows were announced in the
Stambrook was recognized for his contributions to the understanding of in vivo mutagenesis and recombination between homologous chromosomes, as well exceptional service as president of the Environmental Mutagen Society, a society that deals with how DNA is damaged and the cellular mechanisms by which it is repaired, and as the editor of the journal Mutation Research.
A UC faculty member since 1985, Stambrook currently holds more than $5.5 million in research grants. He has presented at more than 60 national and international meetings and published more than 170 scientific manuscripts. He currently serves as scientific director for the Israel Cancer Research Fund and on scientific review panels for the National Institutes of Health and other national agencies. In addition, he is a 15-year board member for the
The AAAS is the worlds largest general scientific society and publisher of the journal Science. Founded in 1848, the society includes more than 260 affiliated societies and academies of science, serving 10 million individuals. A nonprofit organization, the society is open to all and fulfills its mission to advance science and serve society through initiatives in science policy, international programs and science education.
Robert Richardson, PhD, is a professor of philosophy in the McMicken College of Arts and Sciences.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.